UBS Group’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $283K | Sell |
88,490
-9,245
| -9% | -$29.6K | ﹤0.01% | 5262 |
|
|
2025
Q1 | $396K | Sell |
97,735
-7,616
| -7% | -$30.8K | ﹤0.01% | 4838 |
|
|
2024
Q4 | $1.12M | Buy |
105,351
+20,662
| +24% | +$219K | ﹤0.01% | 4137 |
|
|
2024
Q3 | $2.09M | Buy |
84,689
+904
| +1% | +$22.3K | ﹤0.01% | 2992 |
|
|
2024
Q2 | $2.36M | Sell |
83,785
-3,025
| -3% | -$85.3K | ﹤0.01% | 2702 |
|
|
2024
Q1 | $3.53M | Buy |
86,810
+70
| +0.1% | +$2.85K | ﹤0.01% | 2503 |
|
|
2023
Q4 | $1.43M | Buy |
86,740
+46,979
| +118% | +$775K | ﹤0.01% | 3149 |
|
|
2023
Q3 | $1.51M | Sell |
39,761
-386
| -1% | -$14.6K | ﹤0.01% | 2776 |
|
|
2023
Q2 | $2.21M | Buy |
40,147
+1,419
| +4% | +$78K | ﹤0.01% | 2611 |
|
|
2023
Q1 | $1.67M | Buy |
38,728
+781
| +2% | +$33.6K | ﹤0.01% | 2754 |
|
|
2022
Q4 | $1.49M | Buy |
37,947
+753
| +2% | +$29.6K | ﹤0.01% | 2806 |
|
|
2022
Q3 | $1.98M | Buy |
37,194
+36,186
| +3,590% | +$1.92M | ﹤0.01% | 2369 |
|
|
2022
Q2 | $66K | Buy |
1,008
+390
| +63% | +$25.5K | ﹤0.01% | 4717 |
|
|
2022
Q1 | $45K | Sell |
618
-10,315
| -94% | -$751K | ﹤0.01% | 5576 |
|
|
2021
Q4 | $774K | Buy |
+10,933
| New | +$774K | ﹤0.01% | 3639 |
|
|
2021
Q3 | – | Sell |
-1,722
| Closed | -$463K | – | 8503 |
|
|
2021
Q2 | $463K | Sell |
1,722
-997
| -37% | -$268K | ﹤0.01% | 3802 |
|
|
2021
Q1 | $774K | Buy |
+2,719
| New | +$774K | ﹤0.01% | 3584 |
|
|
2020
Q4 | – | Sell |
-5
| Closed | -$2K | – | 7443 |
|
|
2020
Q3 | $2K | Sell |
5
-108
| -96% | -$43.2K | ﹤0.01% | 6768 |
|
|
2020
Q2 | $24K | Buy |
+113
| New | +$24K | ﹤0.01% | 5583 |
|